450 related articles for article (PubMed ID: 19622574)
1. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation.
Jean G; Souberbielle JC; Chazot C
Nephrol Dial Transplant; 2009 Dec; 24(12):3799-805. PubMed ID: 19622574
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients.
Tokmak F; Quack I; Schieren G; Sellin L; Rattensperger D; Holland-Letz T; Weiner SM; Rump LC
Nephrol Dial Transplant; 2008 Dec; 23(12):4016-20. PubMed ID: 18593741
[TBL] [Abstract][Full Text] [Related]
4. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.
Hiremath GS; Cettomai D; Baynes M; Ratchford JN; Newsome S; Harrison D; Kerr D; Greenberg BM; Calabresi PA
Mult Scler; 2009 Jun; 15(6):735-40. PubMed ID: 19383644
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D deficiency and associated factors in hemodialysis patients.
Jean G; Charra B; Chazot C
J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
[TBL] [Abstract][Full Text] [Related]
7. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
Leventis P; Kiely PD
Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
[TBL] [Abstract][Full Text] [Related]
8. Low-dose cholecalciferol supplementation and dual vitamin D therapy in haemodialysis patients.
Dusilová-Sulková S; Šafránek R; Vávrová J; Horáček J; Pavlíková L; Palička V
Int Urol Nephrol; 2015 Jan; 47(1):169-76. PubMed ID: 25262147
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of an oral, 10-day course of high-dose calciferol in correcting vitamin D deficiency.
Wu F; Staykova T; Horne A; Clearwater J; Ames R; Mason B; Orr-Walker B; Gamble G; Scott M; Reid I
N Z Med J; 2003 Aug; 116(1179):U536. PubMed ID: 14513083
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of body weight-adapted oral cholecalciferol substitution in dialysis patients with vitamin D deficiency.
Zitt E; Sprenger-Mähr H; Mündle M; Lhotta K
BMC Nephrol; 2015 Aug; 16():128. PubMed ID: 26238347
[TBL] [Abstract][Full Text] [Related]
11. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
[TBL] [Abstract][Full Text] [Related]
12. The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV-1-infected patients.
van den Bout-van den Beukel CJ; van den Bos M; Oyen WJ; Hermus AR; Sweep FC; Tack CJ; Bosch ME; Burger DM; Koopmans PP; van der Ven AJ
HIV Med; 2008 Oct; 9(9):771-9. PubMed ID: 18754805
[TBL] [Abstract][Full Text] [Related]
13. Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease.
Oksa A; Spustová V; Krivosíková Z; Gazdíková K; Fedelesová V; Lajdová I; Stefíková K; Bernasovská G; Zilinská Z; Dzúrik R
Kidney Blood Press Res; 2008; 31(5):322-9. PubMed ID: 18802363
[TBL] [Abstract][Full Text] [Related]
14. Elevated PTH levels in hypovitaminosis D are more rapidly suppressed by the administration of 1,25-dihydroxy-vitamin D3 than by vitamin D3.
Theiler R; Bischoff H; Tyndall A; Stähelin HB
Int J Vitam Nutr Res; 1998; 68(1):36-41. PubMed ID: 9503046
[TBL] [Abstract][Full Text] [Related]
15. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D.
Marckmann P; Agerskov H; Thineshkumar S; Bladbjerg EM; Sidelmann JJ; Jespersen J; Nybo M; Rasmussen LM; Hansen D; Scholze A
Nephrol Dial Transplant; 2012 Sep; 27(9):3523-31. PubMed ID: 22822092
[TBL] [Abstract][Full Text] [Related]
17. Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium.
Spasovski G; Gelev S; Masin-Spasovska J; Selim G; Sikole A; Vanholder R
Bone; 2007 Oct; 41(4):698-703. PubMed ID: 17643363
[TBL] [Abstract][Full Text] [Related]
18. Correction of preoperative vitamin D deficiency after Roux-en-Y gastric bypass surgery.
Nelson ML; Bolduc LM; Toder ME; Clough DM; Sullivan SS
Surg Obes Relat Dis; 2007; 3(4):434-7. PubMed ID: 17400028
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a new solid formulation of calcium and vitamin D in institutionalized elderly subjects. A randomized comparative trial versus separate administration of both constituents.
Sebert JL; Garabedian M; Chauvenet M; Maamer M; Agbomson F; Brazier M
Rev Rhum Engl Ed; 1995 Apr; 62(4):288-94. PubMed ID: 7606425
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients.
Saab G; Young DO; Gincherman Y; Giles K; Norwood K; Coyne DW
Nephron Clin Pract; 2007; 105(3):c132-8. PubMed ID: 17228173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
